• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较局限性黏液样脂肪肉瘤患者的术前和术后放疗。

Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma.

机构信息

Department of Orthopaedic Surgery, Nara Medical University, Nara, Japan.

Department of Rehabilitation Medicine, Nara Medical University, Nara, Japan.

出版信息

Jpn J Clin Oncol. 2023 Dec 7;53(12):1153-1161. doi: 10.1093/jjco/hyad119.

DOI:10.1093/jjco/hyad119
PMID:37814462
Abstract

BACKGROUND

Myxoid liposarcoma is more radiosensitive than other soft tissue sarcomas, and radiotherapy has been reported to reduce tumour size. This study was performed to compare the rates of local recurrence, survival and wound complications between pre- and post-operative radiotherapy for localized myxoid liposarcoma.

METHODS

From the Japanese Nationwide Bone and Soft Tissue Tumor Registry database, 200 patients with localized myxoid liposarcoma who received pre- (range, 30-56 Gy) or post-operative (range, 45-70 Gy) radiotherapy and surgery were included in this retrospective study. Propensity score matching was used to adjust for background differences between patients who received pre- and post-operative radiotherapy.

RESULTS

Local recurrence occurred in five (5.0%) and nine (9.0%) patients in the pre- and post-operative radiotherapy groups, respectively (both n = 100). The median follow-up time from diagnosis was 40.5 months (IQR, 26.3-74). Univariate analysis showed a similar risk of local recurrence between the pre- and post-operative radiotherapy groups (5-year local recurrence-free survival 94.9% [95% CI 87.0-98.1] vs. 89.0% [95% CI 79.6-94.3]; P = 0.167). Disease-specific survival was similar between the pre- and post-operative radiotherapy groups (5-year disease-specific survival 88.1% [95% CI 75.5-94.6] vs. 88.4% [95% CI 77.3-94.5]; P = 0.900). The incidence of wound complications was similar between the pre- and post-operative radiotherapy groups (7.0% vs. 12.0%; P = 0.228).

CONCLUSIONS

There was no difference in local recurrence, survival or incidence of wound complications between pre- and post-operative radiotherapy for localized myxoid liposarcoma. Therefore, pre-operative radiotherapy for myxoid liposarcoma provides clinical results equivalent to post-operative radiotherapy.

摘要

背景

黏液样脂肪肉瘤比其他软组织肉瘤更具放射敏感性,放疗已被报道可缩小肿瘤体积。本研究旨在比较局部黏液样脂肪肉瘤术前和术后放疗的局部复发率、生存率和伤口并发症发生率。

方法

从日本全国骨与软组织肿瘤登记数据库中,纳入 200 例接受局部黏液样脂肪肉瘤术前(范围:30-56 Gy)或术后(范围:45-70 Gy)放疗和手术的患者,进行回顾性研究。采用倾向评分匹配法调整两组患者的背景差异。

结果

术前和术后放疗组分别有 5 例(5.0%)和 9 例(9.0%)患者发生局部复发(每组 n=100)。从诊断到随访的中位时间为 40.5 个月(IQR:26.3-74)。单因素分析显示,两组的局部复发风险相似(5 年局部无复发生存率 94.9%[95%CI 87.0-98.1] vs. 89.0%[95%CI 79.6-94.3];P=0.167)。两组患者的疾病特异性生存率也相似(5 年疾病特异性生存率 88.1%[95%CI 75.5-94.6] vs. 88.4%[95%CI 77.3-94.5];P=0.900)。两组的伤口并发症发生率也相似(7.0% vs. 12.0%;P=0.228)。

结论

局部黏液样脂肪肉瘤术前和术后放疗的局部复发、生存或伤口并发症发生率无差异。因此,黏液样脂肪肉瘤的术前放疗可提供与术后放疗相当的临床结果。

相似文献

1
Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma.比较局限性黏液样脂肪肉瘤患者的术前和术后放疗。
Jpn J Clin Oncol. 2023 Dec 7;53(12):1153-1161. doi: 10.1093/jjco/hyad119.
2
Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.放射敏感性转化为肢体黏液样脂肪肉瘤出色的局部控制:与其他软组织肉瘤的比较。
Cancer. 2009 Jul 15;115(14):3254-61. doi: 10.1002/cncr.24375.
3
Is perioperative chemotherapy effective in patients with localized myxoid liposarcoma?局部黏液样脂肪肉瘤患者围手术期化疗有效吗?
Jpn J Clin Oncol. 2024 Mar 9;54(3):297-304. doi: 10.1093/jjco/hyad179.
4
Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.肌间肢体黏液样脂肪肉瘤可在新辅助放疗后通过边缘切除进行治疗。
Eur J Surg Oncol. 2023 Feb;49(2):362-367. doi: 10.1016/j.ejso.2022.09.008. Epub 2022 Sep 27.
5
Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.四肢和躯干壁纯黏液样脂肪肉瘤的临床病理预后因素。
Clin Orthop Relat Res. 2010 Nov;468(11):3041-6. doi: 10.1007/s11999-010-1396-3.
6
Radiological progression of extremity soft tissue sarcoma following pre-operative radiotherapy predicts for poor survival.术前放疗后肢体软组织肉瘤的放射学进展预示着预后不良。
Br J Radiol. 2022 Feb 1;95(1130):20210936. doi: 10.1259/bjr.20210936. Epub 2021 Dec 3.
7
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.保肢手术联合放疗治疗黏液样脂肪肉瘤的局部控制率极佳且失败模式独特。
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):760-5. doi: 10.1016/j.ijrobp.2007.07.2337. Epub 2007 Sep 24.
8
Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy.脂肪肉瘤:保肢手术和放射治疗后的结局及预后因素
Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):311-9. doi: 10.1016/s0360-3016(96)00265-9.
9
Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma.新辅助大分割放疗在局部晚期黏液样脂肪肉瘤患者中的疗效
Eur J Surg Oncol. 2016 Jun;42(6):891-8. doi: 10.1016/j.ejso.2016.02.258. Epub 2016 Mar 18.
10
Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.黏液样脂肪肉瘤:43 例患者的局部复发和转移模式。
BMC Cancer. 2018 Mar 20;18(1):304. doi: 10.1186/s12885-018-4226-8.

引用本文的文献

1
Evaluation of Prognostic Factors in Myxoid Liposarcoma Treated with Combined Neoadjuvant Radiotherapy and Surgical Excision: Systematic Review.新辅助放疗联合手术切除治疗黏液样脂肪肉瘤的预后因素评估:系统评价
Diseases. 2025 Jun 6;13(6):177. doi: 10.3390/diseases13060177.
2
"Enhancing Liposarcoma Prognosis - A New Predictive Scoring System Integrating Histopathological Insights".提高脂肪肉瘤预后——一种整合组织病理学见解的新预测评分系统
Cancer Manag Res. 2025 Feb 17;17:331-348. doi: 10.2147/CMAR.S504889. eCollection 2025.